Creatine Encyclopedia — Scientific Background

What Is Creatine?

Creatine (CAS 6020-87-7), chemically known as N-(aminoiminomethyl)-N-methylglycine monohydrate or 2-[carbamimidoyl(methyl)amino]acetic acid, is a naturally occurring non-protein molecule that is the primary component of phosphocreatine, which cells utilize for ATP regeneration. It is a white, crystalline powder that is sparingly soluble in water. Approximately 95% of the body’s total creatine and phosphocreatine stores are found in skeletal muscle, with the remaining amounts distributed in the brain, testes, blood, and various other tissues.

The Phosphocreatine Energy System

Creatine‘s primary physiological function is to facilitate the recycling of adenosine triphosphate (ATP) through the phosphocreatine energy system. When muscle cells contract, ATP is hydrolyzed to ADP and inorganic phosphate, releasing energy. The creatine kinase enzyme then catalyzes the transfer of a phosphate group from phosphocreatine to ADP, rapidly regenerating ATP. This system is particularly critical during short-duration, high-intensity activities such as sprinting, jumping, and weightlifting, where the demand for ATP exceeds the rate at which it can be produced through oxidative phosphorylation.

Typically, both creatine and phosphocreatine are present in skeletal muscle at a concentration of 120 mmol/kg of dry muscle mass; supplementation can increase this level to 160 mmol/kg. To maintain normal (unsupplemented) creatine levels, an individual requires 1–3 g of creatine daily.

Mechanisms of Action

Muscle Strength and Power Enhancement

Creatine supplementation increases intramuscular phosphocreatine stores, enhancing the capacity for rapid ATP regeneration during high-intensity exercise. A systematic review and meta-analysis of 69 studies with 1,937 participants demonstrated that creatine plus resistance training produced small but statistically significant improvements in bench/chest press strength (WMD = 1.43 kg, p = 0.002), squat strength (WMD = 5.64 kg, p = 0.001), vertical jump (WMD = 1.48 cm, p = 0.01), and Wingate peak power (WMD = 47.81 Watts, p = 0.004) when compared to placebo. Subgroup analysis revealed significant increases in bench/chest press (WMD = 1.81 kg, p = 0.002), leg press (WMD = 8.30 kg, p = 0.004), and squat strength (WMD = 6.46 kg, p = 0.001) for younger adults.

Lean Mass Accrual

Creatine supplementation combined with resistance training significantly enhances muscle strength and lean body mass. A three-level meta-analysis of resistance training combined with creatine supplementation demonstrated significant increases in upper-body strength (g = 0.54, p < 0.001). In older adults, creatine combined with resistance training significantly improved lower limb strength (SMD = 0.29 [95% CI 0.00–0.57]) and lean tissue mass, particularly in interventions lasting up to 32 weeks.

Cellular Bioenergetics and Cognitive Function

Creatine plays a critical role in brain Energy Metabolism through the creatine kinase/phosphocreatine system. The presence of brain-specific isoforms of creatine kinase, which are essential for the ATP-phosphocreatine system, supports the role of creatine in brain function. Clinical research is investigating creatine supplementation for its potential to increase brain creatine levels and support cognitive function in aging and neurodegenerative conditions. A pilot trial in Alzheimer’s disease patients investigated 20 g/day of creatine monohydrate for 8 weeks and measured brain creatine and cognition.

The Bioavailability Challenge

Despite its well-established efficacy, conventional creatine monohydrate presents significant formulation challenges. The compound has poor aqueous solubility, and while low-dose loading periods have shown a 53% absorption rate—reducing the amount of supplemental creatine waste—it takes approximately four weeks to reach muscle saturation. Gastrointestinal discomfort is commonly reported at effective doses, which may limit adherence.

Creatine absorption occurs primarily through the sodium-dependent creatine transporter (SLC6A8) in the intestinal epithelium and in muscle cells. This transporter is saturable, meaning that increasing oral doses do not proportionally increase absorption. The liposomal delivery system addresses these limitations by providing an alternative absorption pathway that bypasses the saturable transporter mechanism.

Liposomal Creatine

Liposomal encapsulation of creatine provides a fundamentally different delivery mechanism from conventional forms. Liposomal creatine consists of creatine monohydrate encapsulated in liposomal components (phosphatidylcholine). These liposomes are small lipid packages that increase and speed absorption by the gut. This delivery system:

• Protects creatine from degradation during digestive transit

• Enhances intestinal absorption through lipid-mediated pathways

• Provides an alternative absorption route that bypasses the saturable creatine transporter

• Reduces gastrointestinal discomfort by minimizing direct mucosal contact

Published product data demonstrates up to 8.5 times higher creatine levels in skeletal muscles compared to creatine monohydrate alone. The liposomal formulation is not known to alter the inherent safety profile of creatine and may further enhance its tolerability and absorption efficiency.

Clinical Evidence

Muscle Strength and Power — Meta-Analysis

A systematic review and meta-analysis of 69 randomized controlled trials with 1,937 participants quantified the effects of creatine supplementation on upper- and lower-body muscular strength and power. Creatine plus resistance training produced small but statistically significant improvements in bench/chest press strength (WMD = 1.43 kg, p = 0.002), squat strength (WMD = 5.64 kg, p = 0.001), vertical jump (WMD = 1.48 cm, p = 0.01), and Wingate peak power (WMD = 47.81 Watts, p = 0.004) when compared to placebo. Subgroup analysis based on age revealed significant increases in bench/chest press (WMD = 1.81 kg, p = 0.002), leg press (WMD = 8.30 kg, p = 0.004), and squat strength (WMD = 6.46 kg, p = 0.001) for younger adults.

Lean Mass and Muscle Strength in Older Adults

A systematic review and meta-analysis of creatine supplementation combined with resistance training in older adults demonstrated that creatine significantly improved lower limb strength (SMD = 0.29 [95% CI 0.00–0.57]) and lean tissue mass compared to placebo plus resistance training, particularly in interventions lasting up to 32 weeks.

Brain Creatine and Cognition

A pilot trial in Alzheimer‘s disease patients investigated the feasibility of 20 g/day creatine monohydrate for 8 weeks in 20 patients, measuring compliance and brain creatine levels. A separate randomized controlled pilot study in patients with mild traumatic brain injury used a fixed daily dose of 5 g of creatine monohydrate for seven weeks. The presence of brain-specific isoforms of creatine kinase, essential for the ATP-phosphocreatine system, further supports the role of creatine in brain function.

Postmenopausal Women

A systematic review and meta-analysis evaluated creatine monohydrate for lean mass, strength, and bone density in postmenopausal women, with all trials measuring body composition via DXA and five trials measuring 1RM strength (leg press and/or bench press).

Safety and Regulatory

Creatine monohydrate is one of the most extensively studied dietary supplement ingredients with an established safety record. Clinical trials have used creatine at doses of 5 g/day for seven weeks, 20 g/day for 8 weeks, and loading doses of 20 g/day for 5–7 days followed by maintenance doses of 3–5 g/day. The standard loading protocol of 0.3 g/kg/day for 5–7 days followed by 3–5 g/kg/day maintenance is widely used in clinical research.

Creatine is generally well tolerated. The most commonly reported side effects are gastrointestinal discomfort, including nausea, diarrhea, and stomach cramps, particularly at high doses. Liposomal encapsulation helps reduce these side effects through improved absorption and reduced gastrointestinal mucosal contact.

Creatine monohydrate is widely commercialized as a dietary supplement ingredient and is generally recognized as safe (GRAS) for use in food and dietary supplements. It is the only form of creatine with an established safety record and universally recognized efficacy. Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

69$/KG